Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
News|Articles|January 15, 2026
Therapies to Watch in 1H 2026
Author(s)Noah Stansfield
We highlighted a few investigational cell and gene therapy candidates to keep an eye on in the first half of the new year.
Advertisement
Advertisement
As 2026 kicks off, CGTLive® is taking a look at some of the notable investigational cell and gene therapy candidates in the pipeline. Whether they target a disease area with high unmet need, have inventive mechanisms, or are otherwise notable, here are a few of the investigational products we are keeping our eye in the first half of this year.
Related to this article
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Advertisement
Advertisement